← Back to all trials
Not Yet Recruiting
NCT07780214
EHBM-Based Intervention for Polycystic Ovarain Syndrome Among High Female School Students
Conditions: Polycystic Ovarian Syndrome
Sex: Female
Ages: 16 Years – 18 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 144
Sponsor: Salwan Abed Laftah
Location: University of Baghdad Baghdad Baghdad Governorate
Summary
This study aims to examine efficacy of The Expanded Health Belief model-based intervention in enhancing female high school students' adherence to polycystic ovary syndrome health-protective behaviors.
Eligibility Criteria
Inclusion Criteria:
* Female high school students enrolled in the selected schools during the study period.
* Be within the predefined age range specified in the research protocol (for example, 15-18 years).
* Be able to read and understand the language used in the intervention and questionnaires.
* Be willing to participate in the study.
* Have no previously diagnosed PCOS.
* Not be currently participating in another structured lifestyle or PCOS educational intervention.
Exclusion Criteria:
* Have a previously diagnosed PCOS.
* Have a medical condition that prevents or significantly limits physical activity recommended in the intervention.
* Have a cognitive, learning, or communication difficulty that prevents them from understanding the intervention or completing the questionnaire.
* Are currently participating in another structured lifestyle, weight-management, or PCOS educational program.
* Are receiving a treatment or intervention that could substantially influence the study outcomes.
* Are absent from a predetermined proportion of intervention sessions (for example, more than 20%-25%).
* Fail to complete the baseline assessment or required post-intervention assessment.
* Withdraw their consent/assent at any stage of the study.
* Become unavailable because of transfer to another school, prolonged absence, or other circumstances that prevent completion of the
Source: ClinicalTrials.gov (NCT07780214). StuddyBuddy aggregates publicly available trial information.